Bausch & Lomb Corp (TSX:BLCO)
C$ 22.89 -0.83 (-3.5%) Market Cap: 8.16 Bil Enterprise Value: 15.08 Bil PE Ratio: 0 PB Ratio: 0.93 GF Score: 79/100

Bausch + Lomb Corp at Goldman Sachs Healthcare Conference Transcript

Jun 9, 2026 / 05:20 PM GMT
Release Date Price: C$21.62 (+2.46%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BLCO.N - Bausch + Lomb Corp
Bausch + Lomb Corp at Goldman Sachs Healthcare Conference
Jun 09, 2026 / 05:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
That's great, but it was a very hard choice, I imagine. Yeah, I like mine.

Great guy.

We'll go ahead and get started. Good afternoon, everybody. Very pleased to welcome the management team here from Bausch & Lomb. Pleased to have Brent Saunders, Chief Executive Officer and Yahya Hashad, Chief Medical Officer. Great opportunity here to dive into strategy, but also just the emerging product portfolio given what you had introduced to the investment community in November of last year at your analyst meeting and I think this sort of.

Multitudes of product launches you have across the different businesses. So appreciate the opportunity to be able to dive into that. But maybe we just start, Brent,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot